Optain

Optain is an AI-enabled retinal screening company that combines a portable camera with advanced algorithms to detect over 140 eye and systemic conditions non-invasively at the point of care. The platform screens for diabetic retinopathy, glaucoma, macular degeneration, and cardiovascular risk in under 60 seconds with over 90% accuracy. Founded in 2023 and backed by Aegis Ventures and Northwell Health, Optain targets clinical and primary care settings globally.